Food Effect of VS-6766 in Healthy Adult Subjects

Status Completed

Clinical Trial Summary

An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766

Clinical Trial Description

This is an open-label, randomized, 2-way, 2-period crossover, Food Effect study. On Day 1 of each period, subjects will receive a single oral dose of VS-6766 administered in a 2-way crossover fashion either under fasting conditions or following a standardized high-fat/high-calorie meal. PK sampling for VS-6766 will be collected predose and postdose. There will be a washout period between doses. ;

Study Design

Related Conditions & MeSH terms

Food Effect

Clinical Trial Details

NCT number	NCT05187169
Study type	Interventional
Source	Verastem, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	December 16, 2021
Completion date	April 12, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04501640` - A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants	Phase 4
Completed	`NCT01224587` - Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions	Phase 1
Withdrawn	`NCT02560363` - A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects	Phase 1
Completed	`NCT02017236` - A Food Effect Phase I Study of the Volitinib in Healthy Subjects	Phase 1
Completed	`NCT03150498` - A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001	Phase 1
Completed	`NCT01686217` - A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K	Phase 1
Completed	`NCT01322464` - Study to Assess Food Effect on Sativex Bioavailability	Phase 1
Completed	`NCT03885778` - A Food Effect Study of Besifovir in Healthy Subjects	Phase 4
Completed	`NCT05690932` - A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers	Phase 1
Completed	`NCT05217732` - Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers	Phase 1